Gut Microbiota and Tacrolimus Dosing in Kidney Transplantation
Open accessThe DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Tacrolimus dosing to establish therapeutic levels in recipients of organ transplants is a challenging task because of much interpatient and intrapatient variability in drug absorption, metabolism, and disposition. In view of the reported impact of gut microbial species on drug metabolism, we investigated the relationship between the gut microbiota and tacrolimus dosing requirements in this pilot study of adult kidney transplant recipients. Serial fecal specimens were collected during the first month of transplantation from 19 kidney transplant recipients who either required a 50% increase from initial tacrolimus dosing during the first month of transplantation (Dose Escalation Group, n=5) or did not require such an increase (Dose Stable Group, n=14). We characterized bacterial composition in the fecal specimens by deep sequencing of the PCR amplified 16S rRNA V4-V5 region and we investigated the hypothesis that gut microbial composition is associated with tacrolimus dosing requirements. Initial tacrolimus dosing was similar in the Dose Escalation Group and in the Stable Group (4.2 ± 1.1 mg/day vs. 3.8 ± 0.8 mg/day, respectively, P=0.61, two-way between-group ANOVA using contrasts) but became higher in the Dose Escalation Group than in the Dose Stable Group by the end of the first transplantation month (9.6 ± 2.4 mg/day vs. 3.3 ± 1.5 mg/day, respectively, P<0.001). Our systematic characterization of the gut microbial composition identified that fecal Faecalibacterium prausnitzii abundance in the first week of transplantation was 11.8% in the Dose Escalation Group and 0.8% in the Dose Stable Group (P=0.002, Wilcoxon Rank Sum test, P<0.05 after Benjamini-Hochberg correction for multiple hypotheses). Fecal Faecalibacterium prausnitzii abundance in the first week of transplantation was positively correlated with future tacrolimus dosing at 1 month (R=0.57, P=0.01) and had a coefficient ± standard error of 1.0 ± 0.6 (P=0.08) after multivariable linear regression. Our novel observations may help further explain inter-individual differences in tacrolimus dosing to achieve therapeutic levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A study examining kidney transplant patients found a positive correlation between patients that required an increase in tacrolimus dosing and the abundance of the gut bacterium Faecalibacterium prausnitzii149 (Fig. 5).”
From The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism (2016) · cites this paper as [149]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy
Wang, Q., Garrity, G. M., Tiedje, J. M., & Cole, J. R. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.00062-07 · Cited by 19,885
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549
UCHIME improves sensitivity and speed of chimera detection
Edgar, R. C., Haas, B. J., Clemente, J. C., Quince, C., & Knight, R. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr381 · Cited by 15,114
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100 · cited 1×
“Diet can impact gut microbial composition and structure [43] and whether dietary habits contributed to the gut microbial profile observed in this study is not known since we did not systematically collect diet history from our study subjects.”
BackgroundUltra-high-throughput microbial community analysis on the Illumina HiSeq and MiSeq platforms
Caporaso, J. G., Lauber, C. L., Walters, W. A., Berg-Lyons, D., Huntley, J., Fierer, N., Owens, S. M., Betley, J., Fraser, L., Bauer, M., et al. (2012) · The ISME Journal · doi:10.1038/ismej.2012.8 · Cited by 8,839
UniFrac: a New Phylogenetic Method for Comparing Microbial Communities
Lozupone, C., & Knight, R. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.12.8228-8235.2005 · Cited by 8,227
Pruesse, E., Quast, C., Knittel, K., Fuchs, B. M., Ludwig, W., Peplies, J., & Glockner, F. O. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm864 · Cited by 6,668
Microbial degradation of complex carbohydrates in the gut
Flint, H. J., Scott, K. P., Duncan, S. H., Louis, P., & Forano, E. (2012) · Gut Microbes · doi:10.4161/gmic.19897 · Cited by 2,331
Potential beneficial effects of butyrate in intestinal and extraintestinal diseases
Canani, R. B. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i12.1519 · Cited by 1,381
Cited by
The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism
Spanogiannopoulos, P., Bess, E. N., Carmody, R. N., & Turnbaugh, P. J. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.17 · Cited by 717
Action and function of Faecalibacterium prausnitzii in health and disease
Ferreira-Halder, C. V., Faria, A. V. D. S., & Andrade, S. S. (2017) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2017.09.011 · Cited by 471
The mechanisms of pharmacokinetic food-drug interactions – A perspective from the UNGAP group
Koziolek, M., Alcaro, S., Augustijns, P., Basit, A. W., Grimm, M., Hens, B., Hoad, C. L., Jedamzik, P., Madla, C. M., Maliepaard, M., et al. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.04.003 · Cited by 385
Gut microbiome in chronic kidney disease: challenges and opportunities
Nallu, A., Sharma, S., Ramezani, A., Muralidharan, J., & Raj, D. (2017) · Translational Research · doi:10.1016/j.trsl.2016.04.007 · Cited by 255
Cao, H., Liu, X., An, Y., Zhou, G., Liu, Y., Xu, M., Dong, W., Wang, S., Yan, F., Jiang, K., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-10835-8 · Cited by 253
The Impact of the Gut Microbiota on Drug Metabolism and Clinical Outcome.
Enright, E. F., Gahan, C. G. M., Joyce, S. A., & Griffin, B. T. (2016) · PubMed · Cited by 202
Gut microbiome and kidney disease: a bidirectional relationship
Al Khodor, S., & Shatat, I. F. (2017) · Pediatric Nephrology · doi:10.1007/s00467-016-3392-7 · Cited by 191
“ual differences in tacrolimus dosing [72] and how antibiotic intake may increase the bioavailability of amlodipine and possibly change its therapeutic potency by suppressing gut mi-”
BackgroundReview article: the future of microbiome‐based therapeutics
Gulliver, E. L., Young, R. B., Chonwerawong, M., D'Adamo, G. L., Thomason, T., Widdop, J. T., Rutten, E. L., Rossetto Marcelino, V., Bryant, R. V., Costello, S. P., et al. (2022) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17049 · Cited by 180
Drug Metabolism by the Host and Gut Microbiota: A Partnership or Rivalry?
Swanson, H. I. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.065714 · Cited by 178
Commensal Gut Bacteria Convert the Immunosuppressant Tacrolimus to Less Potent Metabolites
Guo, Y., Crnkovic, C. M., Won, K., Yang, X., Lee, J. R., Orjala, J., Lee, H., & Jeong, H. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.084772 · Cited by 177
Self-citationClinical determinants of calcineurin inhibitor disposition: a mechanistic review
Vanhove, T., Annaert, P., & Kuypers, D. R. J. (2016) · Drug Metabolism Reviews · doi:10.3109/03602532.2016.1151037 · Cited by 171
Focus on the Gut–Kidney Axis in Health and Disease
Stavropoulou, E., Kantartzi, K. M., Tsigalou, C., Konstantinidis, T. G., Romanidou, G. V., Voidarou, C. C., & Bezirtzoglou, E. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2020.620102 · Cited by 142
Safety of Probiotics: Functional Fruit Beverages and Nutraceuticals
Žuntar, I., Petric, Z., Bursać Kovačević, D., & Putnik, P. (2020) · Foods · doi:10.3390/foods9070947 · Cited by 137
Ishikawa, D., Sasaki, T., Osada, T., Kuwahara-Arai, K., Haga, K., Shibuya, T., Hiramatsu, K., & Watanabe, S. (2017) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000975 · Cited by 136
Tsunoda, S. M., Gonzales, C., Jarmusch, A. K., Momper, J. D., & JOSEPH, D. R. (2021) · Clinical Pharmacokinetics · doi:10.1007/s40262-021-01032-y · Cited by 128
Precision Medicine Goes Microscopic: Engineering the Microbiome to Improve Drug Outcomes
Lam, K. N., Alexander, M., & Turnbaugh, P. J. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.06.011 · Cited by 126
Targeting gut microbiota for precision medicine: Focusing on the efficacy and toxicity of drugs
Feng, W., Liu, J., Ao, H., Yue, S., & Peng, C. (2020) · Theranostics · doi:10.7150/thno.47289 · Cited by 121
The Microbiome and Cancer: Is the ‘Oncobiome’ Mirage Real?
Thomas, R. M., & Jobin, C. (2015) · Trends in Cancer · doi:10.1016/j.trecan.2015.07.005 · Cited by 110
The gut microbiome in tuberculosis susceptibility and treatment response: guilty or not guilty?
Eribo, O. A., du Plessis, N., Ozturk, M., Guler, R., Walzl, G., & Chegou, N. N. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03370-4 · Cited by 100
Flannigan, K. L., Taylor, M. R., Pereira, S. K., Rodriguez-Arguello, J., Moffat, A., Alston, L. A., Wang, X., Poon, K. K. H., Beck, P. L., Rioux, K. P., et al. (2018) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2018.05.002 · Cited by 98
Mechanisms of gastrointestinal microflora on drug metabolism in clinical practice
Sun, C., Chen, L., & Shen, Z. (2019) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2019.09.011 · Cited by 97
Metagenomic cross-talk: the regulatory interplay between immunogenomics and the microbiome
Levy, M., Thaiss, C. A., & Elinav, E. (2015) · Genome Medicine · doi:10.1186/s13073-015-0249-9 · Cited by 89
Microbiome mediation of infections in the cancer setting
Taur, Y., & Pamer, E. G. (2016) · Genome Medicine · doi:10.1186/s13073-016-0306-z · Cited by 89
Self-citationGabarre, P., Loens, C., Tamzali, Y., Barrou, B., Jaisser, F., & Tourret, J. (2021) · American Journal of Transplantation · doi:10.1111/ajt.16836 · Cited by 84
Impact of gut microbiota on drug metabolism: an update for safe and effective use of drugs
Noh, K., Kang, Y.-R., Nepal, M. R., Shakya, R., Kang, M. J., Kang, W., Lee, S., Jeong, H. G., & Jeong, T. C. (2017) · Archives of Pharmacal Research · doi:10.1007/s12272-017-0986-y · Cited by 84
Longitudinal Analysis of the Intestinal Microbiota in Liver Transplantation
Kato, K., Nagao, M., Miyamoto, K., Oka, K., Takahashi, M., Yamamoto, M., Matsumura, Y., Kaido, T., Üemoto, S., & Ichiyama, S. (2017) · Transplantation Direct · doi:10.1097/txd.0000000000000661 · Cited by 83
Bringing microbiome-drug interaction research into the clinic
Guthrie, L., & Kelly, L. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.05.009 · Cited by 83
Predicting drug-microbiome interactions with machine learning
McCoubrey, L. E., Gaisford, S., Orlu, M., & Basit, A. W. (2022) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107797 · Cited by 79
Gut microbiome modulates tacrolimus pharmacokinetics through the transcriptional regulation of ABCB1
Degraeve, A. L., Haufroid, V., Loriot, A. E., Gatto, L., Andries, V., Vereecke, L., Elens, L., & Bindels, L. B. (2023) · Microbiome · doi:10.1186/s40168-023-01578-y · Cited by 79
Bromberg, J. S., Hittle, L., Xiong, Y., Saxena, V., Smyth, E. M., Li, L., Zhang, T., Wagner, C., Fricke, W. F., Simon, T., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.121045 · Cited by 73
Exploring the potential impact of probiotic use on drug metabolism and efficacy
Purdel, C. N., Ungurianu, A., Adam-Dima, I., & Margina, D. M. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114468 · Cited by 71
Integrating the gut microbiome and pharmacology
Verdegaal, A. A., & Goodman, A. L. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adg8357 · Cited by 71
Zaza, G., Gassa, A. D., Felis, G. E., Granata, S., Torriani, S., & Lupo, A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178228 · Cited by 70
The gut microbiota in transplant patients
Chong, P. P., & Koh, A. Y. (2019) · Blood Reviews · doi:10.1016/j.blre.2019.100614 · Cited by 58
The Microbiome, Systemic Immune Function, and Allotransplantation
Nellore, A., & Fishman, J. A. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00063-15 · Cited by 57
Interplay between gut microbiota, bone health and vascular calcification in chronic kidney disease
Rodrigues, F. G., Ormanji, M. S., Heilberg, I. P., Bakker, S. J. L., & de Borst, M. H. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13588 · Cited by 56
The alteration of the gut microbiome by immunosuppressive agents used in solid organ transplantation
Gibson, C. M., Childs‐Kean, L. M., Naziruddin, Z., & Howell, C. K. (2020) · Transplant Infectious Disease · doi:10.1111/tid.13397 · Cited by 56
Predictors of tacrolimus pharmacokinetic variability: current evidences and future perspectives
Degraeve, A. L., Moudio, S., Haufroid, V., Eddour, D. C., Mourad, M., Bindels, L. B., & Elens, L. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2020.1803277 · Cited by 56
Gut microbiota and renal transplant outcome
Ardalan, M., & Vahed, S. Z. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.02.114 · Cited by 54
Personalized immunosuppression after kidney transplantation
Cheung, C. Y., & Tang, S. C. W. (2022) · Nephrology · doi:10.1111/nep.14035 · Cited by 52
Gut microbiota in reductive drug metabolism
Guo, Y., Lee, H., & Jeong, H. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.04.002 · Cited by 51
Francke, M. I., Andrews, L. M., Le, H. L., van de Wetering, J., Groningen, M. C. C., van Gelder, T., van Schaik, R. H. N., van der Holt, B., de Winter, B. C. M., & Hesselink, D. A. (2021) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2163 · Cited by 48
Urinary microbiome associated with chronic allograft dysfunction in kidney transplant recipients
Wu, J. F., Muthusamy, A., Al‐Ghalith, G. A., Knights, D., Guo, B., Wu, B., Remmel, R. P., Schladt, D. P., Alegre, M., Oetting, W. S., et al. (2018) · Clinical Transplantation · doi:10.1111/ctr.13436 · Cited by 47
Guirong, Y. E., Minjie, Z., Lixin, Y. U., Ye, J.-S., Lin, Y., & Lisha, S. (2018) · Europe PMC (PubMed Central) · doi:10.12122/j.issn.1673-4254.2018.12.01 · Cited by 47
Jarmusch, A. K., Vrbanac, A. F., Momper, J. D., JOSEPH, D. R., Alhaja, M., Liyanage, M., Knight, R. D., Dorrestein, P. C., & Tsunoda, S. M. (2020) · Clinical and Translational Science · doi:10.1111/cts.12785 · Cited by 48
Machine Learning Predicts Drug Metabolism and Bioaccumulation by Intestinal Microbiota
McCoubrey, L. E., Thomaidou, S., Elbadawi, M., Gaisford, S., Orlu, M., & Basit, A. W. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122001 · Cited by 47
The consequences of altered microbiota in immune-related chronic kidney disease
Lau, W. L., Chang, Y., & Vaziri, N. D. (2020) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaa087 · Cited by 44
Carron, C., de Barros, J.-P. P., Gaiffe, É., Deckert, V., Adda-Rezig, H., Roubiou, C., Laheurte, C., Masson, D., Simula‐Faivre, D., Louvat, P., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01630 · Cited by 43
Potential Implications of Gut Microbiota in Drug Pharmacokinetics and Bioavailability
Flowers, S. A., Bhat, S., & Lee, J. C. (2020) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2428 · Cited by 42
Self-citationImpact of the microbiota on solid organ transplant rejection
Sepulveda, M., Pirozzolo, I., & Alegre, M. (2019) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000702 · Cited by 39
Gut microbiota alterations associated with antibody-mediated rejection after kidney transplantation
Wang, J., Li, X., Wu, X., Wang, Z., Zhang, C., Cao, G., Liu, S., & Yan, T. (2021) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-020-11069-x · Cited by 39
Kriss, M. S., Verna, E. C., Rosen, H. R., & Lozupone, C. (2018) · Transplantation · doi:10.1097/tp.0000000000002568 · Cited by 38
Organ transplantation and gut microbiota: current reviews and future challenges.
Xiao, J., Peng, Z., Liao, Y., Sun, H., Chen, W., Chen, X., Wei, Z., Yang, C., Nussler, A. K., Liu, J., et al. (2018) · Europe PMC (PubMed Central) · Cited by 38
The Critical Role of Innate Immunity in Kidney Transplantation
Cucchiari, D., Podestà, M. A., & Ponticelli, C. E. (2016) · The Nephron journals/Nephron journals · doi:10.1159/000444267 · Cited by 37
Disruption of the Gut Microbiota With Antibiotics Exacerbates Acute Vascular Rejection
Rey, K., Manku, S., Enns, W., Rossum, T. V., Bushell, K. R., Morin, R. D., Brinkman, F. S. L., & Choy, J. C. (2018) · Transplantation · doi:10.1097/tp.0000000000002169 · Cited by 37
Progress and opportunities in microbial community metabolomics
Bhosle, A., Wang, Y., Franzosa, E. A., & Huttenhower, C. (2022) · Current Opinion in Microbiology · doi:10.1016/j.mib.2022.102195 · Cited by 36
Intestinal microbiota and kidney diseases
Kim, M.-G., Yang, J., & Jo, S. (2021) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.21.053 · Cited by 35
Impact of gut microbiota on kidney transplantation
Winichakoon, P., Chaiwarith, R., Chattipakorn, N., & Chattipakorn, S. C. (2021) · Transplantation Reviews · doi:10.1016/j.trre.2021.100668 · Cited by 33
Degraeve, A. L., Bindels, L. B., Haufroid, V., Moudio, S., Boland, L., Delongie, K.-A., Dewulf, J. P., Eddour, D. C., Mourad, M., & Elens, L. (2023) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.3077 · Cited by 33
Gut microbiome alterations precede graft rejection in kidney transplantation patients
Holle, J. B., Reitmeir, R., Behrens, F., Singh, D., Schindler, D., Potapenko, O., McParland, V. J., Anandakumar, H., Kanzelmeyer, N. K., Sommerer, C., et al. (2025) · American Journal of Transplantation · doi:10.1016/j.ajt.2025.02.010 · Cited by 34
Cai, J., Auster, A., Cho, S., & Lai, Z. (2023) · Journal of Advanced Research · doi:10.1016/j.jare.2023.07.002 · Cited by 31
Does the Microbiome Affect the Outcome of Renal Transplantation?
Campbell, P. M., Humphreys, G. J., Summers, A., Konkel, J. E., Cg, K., Augustine, T., & McBain, A. J. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.558644 · Cited by 31
Chan, S., Hawley, C. M., Campbell, K. L., Morrison, M., Campbell, S. B., Isbel, N. M., Francis, R. S., Playford, E. G., & Johnson, D. W. (2019) · Nephrology · doi:10.1111/nep.13670 · Cited by 30
Kidney transplantation and gut microbiota
Chen, Z. W., Chang, X., Ye, Q., Gao, Y., & Deng, R. (2024) · Clinical Kidney Journal · doi:10.1093/ckj/sfae214 · Cited by 30
Rzeczycki, P., Pęciak, O., Plust, M., & Droździk, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262411897 · Cited by 30
A graph neural network approach for predicting drug susceptibility in the human microbiome
Maryam, M., Rehman, M. U., Hussain, I., Tayara, H., & Chong, K. T. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108729 · Cited by 30
Current status of the microbiome in renal transplantation
Ahmad, S. B., & Bromberg, J. S. (2016) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000262 · Cited by 30
Jennings, D. L., Bohn, B., Zuver, A. M., Onat, D., Gaine, M., Royzman, E. A., Hupf, J. C., Brunjes, D. L., Latif, F., Restaino, S. W., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0233646 · Cited by 30
Souai, N., Zidi, O., Mosbah, A., Kosai, I., Manaa, J., Mokhtar, N. B., Asimakis, E. D., Stathopoulou, P. M., Cherif, A., Tsiamis, G., et al. (2020) · Microorganisms · doi:10.3390/microorganisms8111724 · Cited by 30
Microbiota, renal disease and renal transplantation
Salvadori, M., & Tsalouchos, A. (2021) · World Journal of Transplantation · doi:10.5500/wjt.v11.i3.16 · Cited by 28
Microbiome, Immunosenescence, and Chronic Kidney Disease
Stavropoulou, E., Kantartzi, K. M., Tsigalou, C., Aftzoglou, K., Voidarou, C., Konstantinidis, T. G., Chifiriuc, M. C., Thodis, E. D., & Bezirtzoglou, E. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.661203 · Cited by 27
The Gut Microbiota in Kidney Transplantation: A Target for Personalized Therapy?
Martínez, Y. G., Borriello, M., Capolongo, G., Ingrosso, D., & Perna, A. F. (2023) · Biology · doi:10.3390/biology12020163 · Cited by 27
The gut microbiome in solid organ transplantation
Arassi, M. B., Zeller, G., Karcher, N., Zimmermann, M., & Tönshoff, B. (2020) · Pediatric Transplantation · doi:10.1111/petr.13866 · Cited by 27
Influence of the microbiome on solid organ transplant survival
Pirozzolo, I., Li, Z., Sepulveda, M., & Alegre, M. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.04.004 · Cited by 27
Pharmacomicrobiomics: Immunosuppressive Drugs and Microbiome Interactions in Transplantation
Mohamed, M. E., Saqr, A., Staley, C. M., Onyeaghala, G. C., Teigen, L. M., Dorr, C. R., Remmel, R. P., Guan, W., Oetting, W. S., Matas, A. J., et al. (2024) · Transplantation · doi:10.1097/tp.0000000000004926 · Cited by 26
Hutchison, E. R., Kasahara, K., Zhang, Q., Vivas, E. I., Cross, T.-W., & Rey, F. E. (2023) · npj Biofilms and Microbiomes · doi:10.1038/s41522-023-00402-7 · Cited by 26
Drevland, O. M., de Muinck, E. J., Trosvik, P., Hammerstad, M., Kvitne, K. E., Midtvedt, K., Åsberg, A., & Robertsen, I. (2025) · Microbiome · doi:10.1186/s40168-025-02142-6 · Cited by 24
The Impact of Human Microbiotas in Hematopoietic Stem Cell and Organ Transplantation
Sen, T., & Thummer, R. P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.932228 · Cited by 22
Impact of gut microbiota on liver transplantation
Sucu, S., Basarir, K. E., Mihaylov, P. V., Balık, E., Lee, J. T. C., Fridell, J. A., Emamaullee, J. A., & Ekser, B. (2023) · American Journal of Transplantation · doi:10.1016/j.ajt.2023.05.030 · Cited by 22
Self-citationUnveiling gut microbiota's role: Bidirectional regulation of drug transport for improved safety
Wang, J., & Zhou, T. (2024) · Medicinal Research Reviews · doi:10.1002/med.22077 · Cited by 22
Pharmacomicrobiomics of Classical Immunosuppressant Drugs: A Systematic Review
Manes, A., Renzo, T. D., Dodani, L., Reale, A., Gautiero, C., Lauro, M. D., Nasti, G., Manco, F., Muscariello, E., Guida, B., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11092562 · Cited by 21
Effects of intestinal microbiota on pharmacokinetics of cyclosporine a in rats
Zhou, J., Zhang, R., Guo, P., Li, P., Huang, X., Ye, W., Yang, C., Zhou, J., Yang, T., Liu, Y., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1032290 · Cited by 20
Using omics to explore complications of kidney transplantation
Stapleton, C. P., Conlon, P. J., & Phelan, P. J. (2017) · Transplant International · doi:10.1111/tri.13067 · Cited by 20
Physiologic Factors Related to Drug Absorption
Acharya, P. C., Fernandes, C., Mallik, S., Mishra, B., & Tekade, R. K. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-814423-7.00004-6 · Cited by 20
Zheng, Y., Masand, A., Wagner, M. S., Kapur, S., Dadhania, D. M., Lubetzky, M., & Lee, J. R. (2019) · Transplantation Direct · doi:10.1097/txd.0000000000000930 · Cited by 20
Self-citationSalvadori, M., & Rosso, G. (2024) · World Journal of Transplantation · doi:10.5500/wjt.v14.i1.90194 · Cited by 18
Microbiome-driven precision medicine: advancing drug development with pharmacomicrobiomics
Ebadpour, N., Abavisani, M., & Sahebkar, A. (2025) · Journal of drug targeting · doi:10.1080/1061186x.2025.2509283 · Cited by 18
Microbiota in organ transplantation: An immunological and therapeutic conundrum?
Dery, K. J., Kadono, K., Hirao, H., Górski, A., & Kupiec‐Weglinski, J. W. (2020) · Cellular Immunology · doi:10.1016/j.cellimm.2020.104080 · Cited by 18
The Alteration human of gut microbiota and metabolites before and after renal transplantation
Yu, D., Niu, Y., Lian, Z., & Fa, Y. Q. (2021) · Microbial Pathogenesis · doi:10.1016/j.micpath.2021.105191 · Cited by 18
Kanangat, S., & Skaljic, I. (2021) · Human Immunology · doi:10.1016/j.humimm.2021.07.009 · Cited by 18
Ai, P., Xu, S., Yuan, Y., Xu, Z., He, X., Mo, C., Zhang, Y., Yang, X., & Xiao, Q. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26115282 · Cited by 17
The Effect of the Gut Microbiota on Transplanted Kidney Function
Przybyciński, J., Drożdżal, S., Wilk, A., Dziedziejko, V., Szumilas, K., & Pawlik, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021260 · Cited by 17
Blood Profiles of Gut Bacterial Tacrolimus Metabolite in Kidney Transplant Recipients
Guo, Y., Lee, H. W., Edusei, E., Albakry, S., Jeong, H., & Lee, J. R. (2020) · Transplantation Direct · doi:10.1097/txd.0000000000001052 · Cited by 17
Self-citationImmunomodulatory interplay of the microbiome and therapy of rheumatic diseases
Ostrov, B. E., & Amsterdam, D. (2017) · Immunological Investigations · doi:10.1080/08820139.2017.1373828 · Cited by 16
Rapid intestinal and systemic metabolic reprogramming in an immunosuppressed environment
Ma, B., Gavzy, S. J., France, M., Song, Y., Lwin, H. W., Kensiski, A., Saxena, V., Piao, W., Lakhan, R., Iyyathurai, J., et al. (2023) · BMC Microbiology · doi:10.1186/s12866-023-03141-z · Cited by 15
Therapeutic manipulation of the microbiome in liver disease
Parthasarathy, G., Malhi, H., & Bajaj, J. S. (2024) · Hepatology · doi:10.1097/hep.0000000000000987 · Cited by 15
Wu, L., Kensiski, A., Gavzy, S. J., Lwin, H. W., Song, Y., France, M., Lakhan, R., Kong, D., Li, L., Saxena, V., et al. (2025) · JCI Insight · doi:10.1172/jci.insight.186505 · Cited by 15
Khan, M. H., Onyeaghala, G. C., Rashidi, A., Holtan, S. G., Khoruts, A., Israni, A. K., Jacobson, P. A., & Staley, C. M. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2108279 · Cited by 15
Chan, S., Isbel, N. M., Hawley, C. M., Campbell, S. B., Campbell, K. L., Morrison, M., Francis, R. S., Playford, E. G., & Johnson, D. W. (2019) · Medicina · doi:10.3390/medicina55100672 · Cited by 15
Kunasol, C., Chattipakorn, N., & Chattipakorn, S. C. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.177176 · Cited by 14
Metadata
- Authors
- Lee, J. R., Muthukumar, T., Dadhania, D., Taur, Y., Jenq, R. R., Toussaint, N. C., Ling, L., Pamer, E., & Suthanthiran, M.
- Affiliations
- NewYork–Presbyterian Hospital (US)
- Memorial Sloan Kettering Cancer Center (US)
- Corresponding author
- Lee, John R.
- ORCID
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-03-27
- Volume
- 10
- Issue
- 3
- Pages
- e0122399
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4376942
- OpenAlex
- W2073075095
- Cited by
- 211
- References
- 43
- Citations by year
- 2026: 19 · 2025: 22 · 2024: 23 · 2023: 27 · 2022: 18 · 2021: 27 · 2020: 17 · 2019: 16 · 2018: 14 · 2017: 10 · 2016: 13 · 2015: 5
- FWCI
- 11.44
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institutes of Health (KL2TR000458, UL1TR000457, UL1TR002384)
- National Cancer Institute (P30CA008748)
- National Institute of Allergy and Infectious Diseases (R37AI051652)
- National Institute of Diabetes and Digestive and Kidney Diseases (K08DK087824)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- gut microbiota, tacrolimus dosing, kidney transplantation, Faecalibacterium prausnitzii, dose escalation, fecal microbiota, interpatient variability, drug metabolism, immunosuppression, therapeutic drug monitoring
- MeSH terms
- Gastrointestinal Microbiome, Adult, Aged, Bacteria, Dose-Response Relationship, Drug, Feces, Female, Graft Rejection, Humans, Male, Middle Aged, RNA, Ribosomal, 16S, Kidney Transplantation, Tacrolimus, Transplant Recipients
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.